English

Sanolium interim report Q1 Jan-Mar 2024

Report this content

Today Sanolium releases the interim report for the first quarter this year

“We have continued developing the company in line with our strategic direction during the first quarter 2024. Im proud to see such progress among our ongoing projects as well as the trust from new customers as we continue on the journey towards a healthier tomorrow,” says Rami Avidan, CEO of Cambio

A number of important steps has been taken during Q1:

  • Frame agreement with Karolinska Institute
  • Continued preparations for the go live with Sussa, one of the largest IT healthcare projects in Europe
  • Awarded to deliver Cambio Cosmic to Åland
  • Cambio Connect, our annual customer and partner event

Financial highlights:

  • +15% revenue growth in Q1 vs Last Year
  • Issued a senior secured bond of a total amount of 1 000 MSEK

Read the full report for more information

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.

Subscribe

Documents & Links